Investors presentation for the quarter and year ended March 31 2026
NH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Narayana Hrudayalaya reported strong Q4 FY26 results with consolidated revenue of ₹25,938 Mn (up 75.8% YoY) and FY26 revenue of ₹78,960 Mn (up 44% YoY). The company achieved EBITDA of ₹5,392 Mn in Q4 (20.8% margin) and ₹17,169 Mn in FY26 (21.7% margin), with PAT of ₹2,280 Mn and ₹8,105 Mn respectively. India Hospitals EBITDA margin improved from 20.7% in FY25 to 23.1% in FY26. The company operates 55 facilities with 5,945 beds across India, Cayman Islands, and UK (acquired November 2025). Net debt to equity stands at 0.49. Key operational achievements include 750+ robotic cardiac surgeries and 160 TAVIs (20% volume growth). Capex pipeline includes 1,535 beds across 6 locations planned through FY30.
Strong revenue growth driven by UK acquisition and organic expansion; margin improvement in India operations signals operational efficiency gains. The multi-year capex roadmap indicates controlled growth investments, while the healthy EBITDA margins and low leverage ratio support shareholder confidence.